Halley E Gilbert's Net Worth
$9.06 Million
Who is Halley E Gilbert?
Halley E Gilbert has an estimated net worth of $9.06 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., NEOGENOMICS INC, Arcutis Biotherapeutics, Inc., IRONWOOD PHARMACEUTICALS INC, Dermira, Inc., CytomX Therapeutics, Inc., and Achaogen Inc.
SEC CIK
Halley E Gilbert's CIK is 0001601360
Past Insider Trading and Trends
2019 was Halley E Gilbert's most active year for acquiring shares with 12 total transactions. Halley E Gilbert's most active month to acquire stocks was the month of May. 2019 was Halley E Gilbert's most active year for disposing of shares, totalling 12 transactions. Halley E Gilbert's most active month to dispose stocks was the month of January. 2020 saw Halley E Gilbert paying a total of $601,200.00 for 157,500 shares, this is the most they've acquired in one year. In 2020 Halley E Gilbert cashed out on 155,328 shares for a total of $901,264.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vaxcyte, Inc. (PCVX) Snapshot price: $74.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.56% | 1.55K |
—
|
—
| 7.17K |
Jun 6
| |||
Form 4
|
—
|
0
|
$39.17 | -$1,231,230.00 | 5.63K |
Scheduled
|
Jun 3
| ||
Form 4
| +80.00% | 2.5K |
—
|
—
| 5.63K |
Jun 13
| |||
Form 4
|
∞
| 3.13K |
—
|
—
| 3.13K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEOGENOMICS INC (NEO) Snapshot price: $14.035
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.90% | 42.04K |
—
|
—
| 147.4K |
Mar 1
| |||
Form 4
| +77.43% | 45.86K |
—
|
—
| 105.09K |
Dec 30
| |||
Form 4
|
∞
| 59.23K |
—
|
—
| 59.23K |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.71% | 10.14K |
—
|
—
| 18.83K |
Jun 14
| |||
Form 4
| +101.46% | 4.38K |
—
|
—
| 8.69K |
May 31
| |||
Form 4
|
∞
| 4.31K |
—
|
—
| 4.31K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $14.885
Chief Admin Officer & SVP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.45% | -15.33K |
$11.63 | -$178,264.64 | 265.99K |
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
$11.04 | -$121,800.00 | 281.32K |
Scheduled
|
Jan 31
| ||
Form 4
| +17.13% | 41.15K |
—
|
—
| 281.32K |
Dec 16
| |||
Form 4
|
—
|
0
|
$7.44 | -$102,400.00 | 240.17K |
Scheduled
|
Jul 26
| ||
Form 4
| -1.67% | -4.05K |
$10.53 | -$42,699.15 | 238.24K |
Scheduled
|
May 10
| ||
Form 4
| +7.62% | 17.16K |
—
|
—
| 242.29K |
Apr 1
| |||
Form 4
| -4.35% | -10.24K |
$14.31 | -$146,563.87 | 225.13K |
Scheduled
|
Feb 20 - Feb 21
| ||
Form 4
| +65.26% | 92.95K |
$4.89 | $99,995.61 | 235.37K |
Jan 29 - Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +9.24% | 12K |
—
|
—
| 141.9K |
Jul 31
| |||
Form 4
|
—
|
0
|
$12.32 | -$439,127.86 |
0
|
Scheduled
|
Jul 3
| ||
Form 4
| +26.74% | 27.26K |
$14.66 | -$113,483.06 | 129.2K |
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
$11.76 | -$559,650.00 |
0
|
Scheduled
|
Jun 22
| ||
Form 4
| +65.78% | 40K |
—
|
—
| 100.81K |
Feb 27
| |||
Form 4
| -7.65% | -5.04K |
$16.94 | -$85,360.66 | 60.81K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
$10.26 | -$485,631.15 |
0
|
Scheduled
|
Feb 14
| ||
Form 4
|
—
|
0
|
$10.26 | -$181,860.00 |
0
|
Scheduled
|
Nov 11
| ||
Form 4
| -6.40% | -4.41K |
$7.98 | -$187,499.85 | 64.54K |
Scheduled
|
May 25
| ||
Form 4
| +89.17% | 32.5K |
—
|
—
| 68.95K |
Mar 1
| |||
Form 4
| -7.08% | -2.78K |
$8.50 | -$23,613.00 | 36.45K |
Scheduled
|
Feb 24
| ||
Form 4
| +324.46% | 28.75K |
—
|
—
| 37.61K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermira, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||